Premium
Administration of polysaccharides from Antrodia camphorata modulates dendritic cell function and alleviates allergen‐induced T helper type 2 responses in a mouse model of asthma
Author(s) -
Liu KoJiunn,
Leu SyJye,
Su ChingHua,
Chiang BorLuen,
Chen YiLien,
Lee YuehLun
Publication year - 2010
Publication title -
immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.297
H-Index - 133
eISSN - 1365-2567
pISSN - 0019-2805
DOI - 10.1111/j.1365-2567.2009.03175.x
Subject(s) - ovalbumin , immunology , interleukin 4 , lipopolysaccharide , biology , immune system , microbiology and biotechnology , materials science
Summary Asthma is a chronic disease characterized by airway inflammation caused by the dysregulated production of cytokines secreted by allergen‐specific type 2 T helper (Th2) cells. Antrodia camphorata is a commonly used fungus in Asian folk medicine, and A. camphorata polysaccharides are reported to possess anti‐cancer activities. In this study, the immunomodulatory effects of purified fractionated polysaccharides (GF2) from A. camphorata on dendritic cells (DCs) and their potential preventive effects against ovalbumin (OVA) ‐induced asthma were investigated. In the presence of GF2, lipopolysaccharide (LPS) ‐activated DCs exhibited up‐regulated expression of major histocompatibility complex (MHC) class II and co‐stimulatory molecules, as well as enhanced interleukin‐10 (IL‐10) and IL‐12 production. GF2 treatment on LPS‐activated DCs suppressed naïve CD4 + T‐cell proliferation and Th2 cell polarization with IL‐10 production in an allogeneic mixed lymphocyte reaction. In animal experiments, a high dose of GF2 efficiently reduced expression levels of OVA‐specific immunoglobulin G1 (IgG1) and IgE. However, lower doses of GF2 significantly enhanced OVA‐specific IgG2a production. Our data also showed that administration of GF2 dose‐dependently inhibited the development of airway hyperresponsiveness, airway eosinophilia and Th2 responses. OVA‐specific CD4 + T cells from higher doses of GF2‐treated mice had significantly lower proliferative capacities compared with control mice. Moreover, treatment with GF2 significantly increased the high levels of IL‐10 and low levels of interferon‐γ produced by T cells. Taken together, these data indicate that administration of A. camphorata polysaccharides (GF2) may have therapeutic potential when used as an adjuvant for the immunomodulatory treatment of allergic asthma.